ProVascTec
Cork
About ProVascTec
ProVascTec, a preclinical stage cell treatment firm, to stimulate the development of a novel circulatory system and form a natural bypass around arterial occlusions in the peripheral vascular system, particularly below the knee. The paracrine process of stem cells is used by ProVascTec, a preclinical stage cell treatment firm, to stimulate the development of a novel circulatory system and form a natural bypass around arterial occlusions in the peripheral vascular system, particularly below the knee.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $5.2M
- Last round: Grant (Sep 2025)
- Website: provasctec.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/provasctec-38572 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.